Argenica Therapeutics (ASX:AGN) Total Liabilities : A$2.03 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Argenica Therapeutics Total Liabilities?

Argenica Therapeutics's Total Liabilities for the quarter that ended in Dec. 2023 was A$2.03 Mil.

Argenica Therapeutics's quarterly Total Liabilities increased from Dec. 2022 (A$1.33 Mil) to Jun. 2023 (A$1.87 Mil) and increased from Jun. 2023 (A$1.87 Mil) to Dec. 2023 (A$2.03 Mil).

Argenica Therapeutics's annual Total Liabilities increased from Jun. 2021 (A$0.43 Mil) to Jun. 2022 (A$0.74 Mil) and increased from Jun. 2022 (A$0.74 Mil) to Jun. 2023 (A$1.87 Mil).

Argenica Therapeutics Total Liabilities Historical Data

The historical data trend for Argenica Therapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argenica Therapeutics Total Liabilities Chart

Argenica Therapeutics Annual Data

Trend

Jun21

Jun22

Jun23

Total Liabilities

0.43

0.74

1.87

Argenica Therapeutics Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial			0.06	0.74	1.33	1.87	2.03

Argenica Therapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Argenica Therapeutics's Total Liabilities for the fiscal year that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.874	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1.87

Total Liabilities	=	Total Assets (A: Jun. 2023 )	-	Total Equity (A: Jun. 2023 )
	=	9.541	-	7.666
	=	1.88

Argenica Therapeutics's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2.026	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	2.03

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	8.621	-	6.594
	=	2.03

Argenica Therapeutics Total Liabilities Related Terms

Thank you for viewing the detailed overview of Argenica Therapeutics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Argenica Therapeutics (ASX:AGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argenica Therapeutics Ltd (ASX:AGN) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

117 Broadway, Unit 4, Nedlands, WA, AUS, 6009

Website

https://www.argenica.com.au

Argenica Therapeutics Ltd is engaged in the development and commercialization of novel drug candidates. Its ARG007 drug improves outcomes in pre-clinical stroke models and is in the process of being verified for its safety and toxicology before commencing Phase 1 clinical trials in humans.

Argenica Therapeutics (ASX:AGN) Headlines

No Headlines